BusinessExagen Diagnostics to Present Six Scientific Posters at 2016 ACR/ARHP Annual MeetingBy Nasdaq OMXOct 12, 2016, 12:32 PM UTC
BusinessMYnd Analytics, Inc. Announces Appointment of Thomas Tierney to Board of DirectorsBy Nasdaq OMXOct 4, 2016, 12:01 PM UTC
BusinessMYnd Analytics Announces Conversion of Outstanding Notes Following Closing on Last Tranche of $6.0 Million Financing and Recapitalization Including a Reverse Stock Split and Elimination of 99% of Outstanding WarrantsBy Nasdaq OMXSep 20, 2016, 10:03 PM UTC
